HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noa Galtung Selected Research

Noa Galtung Research Topics

Disease

5COVID-19
09/2022 - 01/2021
3Infections
05/2024 - 10/2021
2Bacterial Infections (Bacterial Infection)
05/2024 - 10/2021
2Sepsis (Septicemia)
05/2024 - 10/2022
1Clinical Deterioration
05/2024
1Coinfection
09/2022
1Inflammation (Inflammations)
12/2021
1Cardiovascular Diseases (Cardiovascular Disease)
12/2021
1Virus Diseases (Viral Diseases)
10/2021
1Activated Protein C Resistance (APC Resistance)
01/2021

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
05/2024 - 10/2022
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
05/2024 - 01/2021
1Messenger RNA (mRNA)IBA
10/2022
1Anti-Bacterial Agents (Antibiotics)IBA
09/2022
1Proteins (Proteins, Gene)FDA Link
12/2021
1ProteomeIBA
12/2021
1Blood Proteins (Serum Proteins)IBA
12/2021
1ProcalcitoninIBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1Thromboplastin (Tissue Factor)IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1Protein CIBA
01/2021
1Cell Adhesion MoleculesIBA
01/2021
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2021
1Protein SIBA
01/2021
1Plasminogen Activators (Plasminogen Activator)IBA
01/2021
1PlasminogenIBA
01/2021
1AntithrombinsIBA
01/2021
1Factor V (Coagulation Factor V)IBA
01/2021